Deimante Simaite
Sanofi R&D, Sanofi
Frankfurt Am Main, HE, Germany
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa.
Journal: The journal of allergy and clinical immunology. Global
Published: June 13, 2024
Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
Journal: The Journal of allergy and clinical immunology
Published: March 25, 2022
Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq data.
Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq data.
Journal: NAR genomics and bioinformatics
Published: January 25, 2022
Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
Journal: The British journal of dermatology
Published: December 30, 2020
Prominin-1 (CD133) modulates the architecture and dynamics of microvilli.
Journal: Traffic (Copenhagen, Denmark)
Published: April 09, 2018
Translational regulation shapes the molecular landscape of complex disease phenotypes.
Journal: Nature communications
Published: November 19, 2014
Recessive mutations in PCBD1 cause a new type of early-onset diabetes.
Journal: Diabetes
Published: May 23, 2014
Two novel GATA6 mutations cause childhood-onset diabetes mellitus, pancreas malformation and congenital heart disease.
Journal: Hormone research in paediatrics
Published: October 26, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026